Archives of Medical Sciences. Atherosclerotic Diseases最新文献

{"title":"Analysis of the logistical, economic and minimally invasive cardiac surgical training difficulties in India.","authors":"Ganesh Kumar K Ammannaya, Marco Solinas, Claudio Passino","doi":"10.5114/amsad.2020.97380","DOIUrl":"10.5114/amsad.2020.97380","url":null,"abstract":"<p><p>Significant advances have been made in minimally invasive cardiac surgery (MICS) over the past 3 decades. However, the acceptance and practice of MICS continue to remain low in the developing world owing to several challenges. This study aimed to analyse the logistical, economic and training difficulties in MICS with a special focus on the Indian scenario. A systematic review of the current literature on MICS with an emphasis on these challenges was performed. MICS has been shown to have clear cost-benefit advantage that stems from shorter ICU and hospital stay, lesser transfusion requirements and avoidance of sternal wound complications. However, only limited reports are currently available detailing the economic and training challenges for the application of MICS in the developing world, particularly India. Though several challenges exist in widening MICS practice in India, these can be overcome through a target-oriented approach.</p>","PeriodicalId":8317,"journal":{"name":"Archives of Medical Sciences. Atherosclerotic Diseases","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-07-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/89/2a/AMS-AD-5-41353.PMC7433791.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38294127","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Paroxysmal atrial fibrillation: changes in factor VIII and von Willebrand factor impose early hypercoagulability.","authors":"Mariya Negrinova Negreva,&nbsp;Krasimira Prodanova,&nbsp;Katerina Vitlianova,&nbsp;Christiana Madjova","doi":"10.5114/amsad.2020.97101","DOIUrl":"https://doi.org/10.5114/amsad.2020.97101","url":null,"abstract":"<p><strong>Introduction: </strong>Paroxysmal atrial fibrillation (PAF) is a well-documented prothrombotic state that carries significant embolic risk. However, precise hemostatic changes in the very early stage of the disease are not completely studied. The aim of the study was to study von Willebrand factor (vWF) and coagulation factor VIII (FVIII) plasma levels and activity in the first hours (up to 24 h) of PAF clinical manifestation.</p><p><strong>Material and methods: </strong>We selected consecutively 51 non-anticoagulated patients (26 men, 25 women, mean age: 59.84 ±1.60) with PAF and 52 controls (26 men, 26 women, mean age: 59.50 ±1.46 years) corresponding in gender, accompanying diseases and conducted treatment. The indicators were examined using enzyme-linked immunoassays and photometric tests.</p><p><strong>Results: </strong>All patients were hospitalized between the 2^nd and 24^th h after the onset of arrhythmia (mean: 8.14 ±0.74 h). Higher FVIII levels (107.52 ±3.48% vs. 93.85 ±2.93%, <i>p</i> < 0.05) and activity (200.03 ±11.11% vs. 109.73 ±4.90%, <i>p</i> < 0.001) were found in the PAF group. vWF levels (178.40 ±12.95% vs. 119.53 ±6.12%, <i>p</i> < 0.001) and activity (200.92 ±12.45% vs. 110.80 ±5.14%, <i>p</i> < 0.001) were also higher. These changes did not depend on age, sex, body mass index or CHA₂DS₂-VASc score in the PAF group (<i>p</i> > 0.05). PAF duration was a significant predictor of increased FVIII levels and activity. Increased PAF duration was followed by increased values of the factors (<i>r</i> = 0.85, <i>p</i> < 0.001; <i>r</i> = 0.83, <i>p</i> < 0.001).</p><p><strong>Conclusions: </strong>The results presented an activated coagulation cascade and endothelial injury, suggesting hypercoagulability still in the early hours of PAF. These changes in PAF did not correlate with CHA₂DS₂-VASc score risk factors, outlining PAF as a possible independent embolic risk factor.</p>","PeriodicalId":8317,"journal":{"name":"Archives of Medical Sciences. Atherosclerotic Diseases","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-07-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.5114/amsad.2020.97101","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38294122","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Silent myocardial dysfunction in vitamin D deficiency.","authors":"Pelin Karaca Ozer,&nbsp;Samim Emet,&nbsp;Ekrem Bilal Karaayvaz,&nbsp;Ali Elitok,&nbsp;Ahmet Kaya Bilge,&nbsp;Kamil Adalet,&nbsp;Aytac Oncul","doi":"10.5114/amsad.2020.97110","DOIUrl":"https://doi.org/10.5114/amsad.2020.97110","url":null,"abstract":"<p><strong>Introduction: </strong>Vitamin D (VD) deficiency is a common disease that occurs in all stages of life. A growing number of studies call attention to the relationship between VD deficiency and cardiovascular disease. The aim of this study was to investigate the effect of VD on subclinical left ventricular (LV) function in diabetic and non-diabetic patients with no significant coronary artery disease.</p><p><strong>Material and methods: </strong>We recruited 140 patients (80 diabetics and 60 non-diabetics) with symptoms of stable ischemic heart disease who underwent coronary angiography and who had no significant coronary artery disease in our clinic. The 25(OH)D₃ levels were measured and patients who had 25-(OH)D₃ levels below 20 ng/dl were defined as the VD deficient group. In addition to conventional echocardiographic parameters, tissue Doppler echocardiography was used for LV diastolic functions and 2D speckle tracking strain echocardiography (2D STE) for evaluating the longitudinal deformation indices of the LV myocardium.</p><p><strong>Results: </strong>In all groups, LV global longitudinal strain (GLS) was significantly impaired in patients with VD deficiency (<i>p</i> < 0.001) compared to patients without VD deficiency. LV global longitudinal strain rate (GLSR) was significantly impaired in patients with VD deficiency (<i>p</i> = 0.003). The GLS was negatively associated with 25-(OH)D₃ in the VD deficiency group (<i>r</i> = -0.52623, <i>p</i> < 0.001). Conversely, GLS was positively associated with 25-(OH)D₃ levels in the normal VD group (<i>r</i> = 0.28, <i>p</i> = 0.048).</p><p><strong>Conclusions: </strong>VD deficiency is associated with impaired myocardial GLS. The present study demonstrated that VD deficiency may be the cause of subclinical myocardial dysfunction in patients with or without diabetes mellitus and no history of significant coronary artery disease.</p>","PeriodicalId":8317,"journal":{"name":"Archives of Medical Sciences. Atherosclerotic Diseases","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-07-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.5114/amsad.2020.97110","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38294124","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Implantable cardioverter defibrillators - the past, present and future.","authors":"Ganesh Kumar K Ammannaya","doi":"10.5114/amsad.2020.97103","DOIUrl":"10.5114/amsad.2020.97103","url":null,"abstract":"<p><p>Since their formal introduction in 1980, implantable cardioverter defibrillators (ICDs) have undergone innumerable design modifications through several generations. They are indispensable today in successfully managing fatal ventricular arrhythmias. Their role in averting sudden cardiac death is recognized beyond doubt. Their applications and indications have continuously expanded over the last two decades. This article reviews the salient features in the evolution of ICDs, their current indications, recent advances and future directions. With more advanced detection algorithms, the potential integration with leadless pacing, and the possibility to serve as a remote monitoring device to recognize atrial fibrillation, acute ischemia, or electrolyte imbalance, the application of ICDs is rapidly evolving.</p>","PeriodicalId":8317,"journal":{"name":"Archives of Medical Sciences. Atherosclerotic Diseases","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-07-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/2a/3f/AMS-AD-5-41235.PMC7433784.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38294125","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Comparison of effectiveness and survival after the MitraClip or Carillon procedure for severe functional mitral regurgitation: a single-center retrospective analysis.","authors":"Stephan Heyl, Aria Nikkhoo, Markus Wieszner, Stephan Fichtlscherer, Florian Seeger, Birgit Assmus, Brigitte Luu, Katrin Hemmann, Claudia Walther, Joerg Honold","doi":"10.5114/amsad.2020.97160","DOIUrl":"10.5114/amsad.2020.97160","url":null,"abstract":"<p><strong>Introduction: </strong>Current studies suggest improved survival in patients with severe functional mitral regurgitation (FMR) treated successfully with the MitraClip (MC) compared to medical treatment alone, in addition to a significant reduction of FMR severity. Recently, the Carillon system (CS) has also been shown to significantly reduce FMR. However, whether this beneficial effect of CS also translates into a survival benefit comparable to the MC system has not been investigated so far. The aim of the study was to compare the course of FMR grade and mortality after MC or CS in a retrospective, non-randomized, single-center analysis.</p><p><strong>Material and methods: </strong>A hundred and fifty-four patients with symptomatic FMR 2+ were included in this study (MC: <i>n</i> = 117, CS: <i>n</i> = 37). Baseline characteristics did not differ significantly between groups.</p><p><strong>Results and conclusions: </strong>Initially, the degree of FMR was reduced in the MC group from 2.9 ±0.3 to 1.7 ±0.7 and from 2.7 ±0.5 to 2.1 ±0.7 in the CS group, <i>p</i> within and between groups < 0.01. Within 6 months, FMR remained reduced in the MC group (1.83 ±0.6) and CS group (2.1 ±0.7). One-year survival was 34.8% in the MC group and 54.8% in the CS group (<i>p</i> = 0.663). Median long-term survival was 1.66 years in the MC group and 3.92 years in the CS group, log rank <i>p</i> = 0.001.</p>","PeriodicalId":8317,"journal":{"name":"Archives of Medical Sciences. Atherosclerotic Diseases","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-07-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/2d/8e/AMS-AD-5-41278.PMC7433783.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38294126","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Risk of cardiovascular disease with lipoprotein(a) in familial hypercholesterolemia: a review.","authors":"Jun Watanabe,&nbsp;Masato Hamasaki,&nbsp;Kazuhiko Kotani","doi":"10.5114/amsad.2020.97105","DOIUrl":"https://doi.org/10.5114/amsad.2020.97105","url":null,"abstract":"<p><strong>Introduction: </strong>Lipoprotein(a) (Lp[a]) is a risk factor of cardiovascular disease (CVD). Familial hypercholesterolemia (FH), which exhibits high low-density lipoprotein cholesterol (LDL-C) levels, is a risk factor of CVD. The relationship of Lp(a) with CVD has been characterized in populations specific to FH.</p><p><strong>Material and methods: </strong>Studies reporting on the relationship of Lp(a) with CVD among FH subjects via PubMed up to 2020 were reviewed.</p><p><strong>Results: </strong>Eight studies were identified as eligible. In the meta-analyses, a high Lp(a) level was significantly and predictively associated with CVD compared to a low Lp(a) level in 2 cross-sectional studies (odds ratio = 2.57; 95% confidence interval (CI): 1.16-5.73) and 6 cohort studies (risk/hazard ratio = 1.91; 95% CI: 1.50-2.43). The totally integrated relative risk of these studies was 1.97 (95% CI: 1.57-2.46).</p><p><strong>Conclusions: </strong>FH subjects with high Lp(a) levels can have a high CVD risk, and besides LDL-C, attention should be paid to Lp(a) levels in FH subjects.</p>","PeriodicalId":8317,"journal":{"name":"Archives of Medical Sciences. Atherosclerotic Diseases","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-07-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.5114/amsad.2020.97105","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38294123","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Is there a relationship between epicardial fat tissue thickness and Tp-Te/QT ratio in healthy individuals?","authors":"Mücahid Yılmaz,&nbsp;Hidayet Kayançiçek,&nbsp;Nevzat Gözel,&nbsp;Ertuğrul Kurtoğlu,&nbsp;Özlem Seçen,&nbsp;Pınar Öner,&nbsp;Yusuf Çekici,&nbsp;Mehmet Nail Bilen,&nbsp;Suat Demirkıran,&nbsp;Ökkeş Uku","doi":"10.5114/aoms.2020.96147","DOIUrl":"https://doi.org/10.5114/aoms.2020.96147","url":null,"abstract":"<p><strong>Introduction: </strong>Epicardial fat is a tissue that releases many proinflammatory and atherogenic mediators, with endocrine and paracrine effects on the heart. In this study, the implication of the EFT thickness (EFTt) on transmural dispersion of repolarisation (TDR) was analysed utilizing the T-wave peak to end interval (Tp-Te), the Tp-Te dispersion (Tp-Te (d)), and the Tp-Te/QT ratio.</p><p><strong>Material and methods: </strong>One thousand seven hundred and thirteen subjects were enrolled in the research. The subjects were chosen to be healthy individuals, without any cardiovascular/systemic disorders or risk factors for atherosclerosis. Transthoracic echocardiography (TTE) was applied to all subjects, and EFTt was measured in both diastole and systole. The ECG measurements were taken from standard 12-lead surface ECG.</p><p><strong>Results: </strong>Correlation analysis revealed that the EFTt is highly associated with the Tp-Te interval, Tp-Te/QT ratio, Tp-Te (d), increasing age, body mass index (BMI), body surface area (BSA), left ventricular (LV) mass, LV mass index, plasma glucose during fasting, triglycerides, and low-density lipoprotein cholesterol.</p><p><strong>Conclusions: </strong>The study results showed that increased EFTt was associated with increased TDR values of Tp-Te, Tp-Te (d), and Tp-Te/QT ratio, even in the absence of other factors that could increase TDR and EFTt. Therefore, it can be stated that increased EFTt may cause an increase the risk for ventricular arrhythmia.</p>","PeriodicalId":8317,"journal":{"name":"Archives of Medical Sciences. Atherosclerotic Diseases","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-06-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.5114/aoms.2020.96147","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38160189","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Atheroprotective effects of 17β-oestradiol are mediated by peroxisome proliferator-activated receptor γ in human coronary artery smooth muscle cells.","authors":"Julian Jehle,&nbsp;Vedat Tiyerili,&nbsp;Sandra Adler,&nbsp;Katharina Groll,&nbsp;Georg Nickenig,&nbsp;Ulrich M Becher","doi":"10.5114/amsad.2020.96103","DOIUrl":"https://doi.org/10.5114/amsad.2020.96103","url":null,"abstract":"<p><strong>Introduction: </strong>17β-oestradiol (E2) mediates vasculoprotection in various preclinical and clinical models of atherosclerosis and neointimal hyperplasia. However, the molecular mechanisms underlying these effects are still not fully elucidated. Previous studies have demonstrated the essential role of the peroxisome-proliferator-activated-receptor-γ (PPARγ) in mediating vasculoprotective effects of E2 <i>in vivo</i>. The aim of the current study was to investigate whether PPARγ mediates vasculoprotective mechanisms of E2 in human coronary artery smooth muscle cells (HCASMC).</p><p><strong>Material and methods: </strong>Primary HCASMC were stimulated with E2 (10 nM), the selective oestrogen receptor α (ERα) agonist propylpyrazole triol (PPT) (50 nM) and the selective ERα antagonist methyl-piperidino-pyrazole (MPP) (1 µM), respectively. Changes in PPARγ mRNA, protein expression, and DNA binding affinity were assessed.</p><p><strong>Results: </strong>E2 significantly increased PPARγ expression in HCASMC (1.95 ±0.41-fold; <i>n</i> = 5; <i>p</i> = 0.0335). This effect was mimicked by ERα agonist PPT (1.63 ±0.27-fold; <i>n</i> = 7; <i>p</i> = 0.0489) and was abrogated by co-incubation with ERα antagonist MPP (1.17 ±0.18-fold; <i>n</i> = 3; <i>p</i> _{vs. control} > 0.05). PPARγ-DNA binding activity to PPRE remained unchanged upon stimulation with E2 (0.94 ±0.11-fold; <i>n</i> = 4; <i>p</i> _{vs. control} > 0.05). Pharmacological inhibition of PI3K/Akt by LY294002 abrogated E2-induced expression of PPARγ (0.24 ±0.09-fold; <i>n</i> = 3; <i>p</i> _{vs. E2} = 0.0017).</p><p><strong>Conclusions: </strong>The present study identifies PPARγ as an important downstream mediator of E2-related atheroprotective effects in HCASMC. PPARγ agonism might be a promising therapeutic strategy to prevent neointimal hyperplasia and consecutive cardiovascular events in postmenopausal women with depleted E2 plasma levels.</p>","PeriodicalId":8317,"journal":{"name":"Archives of Medical Sciences. Atherosclerotic Diseases","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-06-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.5114/amsad.2020.96103","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38160188","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Neutrophil to lymphocyte ratio and platelet to lymphocyte ratio are associated with cryptogenic stroke in patients with patent foramen ovale.","authors":"Fatma Nihan Turhan Caglar,&nbsp;Murat Erdem Alp,&nbsp;Nilay Karabulut,&nbsp;Nilgun Isiksacan,&nbsp;Fahrettin Katkat,&nbsp;Hulya Cebe,&nbsp;Ersan Oflar,&nbsp;Didem Melis Oztas,&nbsp;Orhan Rodoplu,&nbsp;Orcun Unal,&nbsp;Cenk Conkbayir,&nbsp;Faruk Akturk,&nbsp;Murat Ugurlucan","doi":"10.5114/amsad.2020.95946","DOIUrl":"https://doi.org/10.5114/amsad.2020.95946","url":null,"abstract":"<p><strong>Introduction: </strong>Although most ischaemic strokes are due to cardioembolism, about 25-40% of strokes are cryptogenic. Patent foramen ovale has been associated with cryptogenic stroke; however, the precise mechanism of this association has not been demonstrated. The aim of this study was to evaluate the association between inflammatory markers and cryptogenic stroke in patients with patent foramen ovale.</p><p><strong>Material and methods: </strong>We included 206 patients with patent foramen ovale. Ninety-four (45.63%) out of 206 patients had had stroke, and 112 (54.37%) had not had stroke. The ratio of the total neutrophil count to the total lymphocyte count was defined as the neutrophil to lymphocyte ratio, and the ratio of the absolute platelet count to the absolute lymphocyte count was determined as the platelet to lymphocyte count.</p><p><strong>Results: </strong>The neutrophil to lymphocyte ratio was significantly higher in patients who had stroke than in those who did not (2.41 ±1.69 vs. 2.19 ±1.74, <i>p</i> = 0.047). Although the platelet to lymphocyte count was also higher in patients who had had stroke than in those who had not, it was not statistically significant (120.94 ±55.45 vs. 118.01 ±52.21, <i>p</i> = 0.729). 1.62 was the cut-off value for neutrophil to lymphocyte ratio to be associated with stroke with 73.4% sensitivity and 45.05% specificity (<i>p</i> = 0.042).</p><p><strong>Conclusions: </strong>This study demonstrated that elevated neutrophil to lymphocyte ratio and platelet to lymphocyte count could be associated with cryptogenic stroke in patients with patent foramen ovale.</p>","PeriodicalId":8317,"journal":{"name":"Archives of Medical Sciences. Atherosclerotic Diseases","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.5114/amsad.2020.95946","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38036030","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Usefulness of resveratrol supplementation in decreasing cardiometabolic risk factors comparing subjects with metabolic syndrome and healthy subjects with or without obesity: meta-analysis using multinational, randomised, controlled trials.","authors":"Consolato Sergi, Bonnie Chiu, Joseph Feulefack, Fan Shen, Brian Chiu","doi":"10.5114/amsad.2020.95884","DOIUrl":"10.5114/amsad.2020.95884","url":null,"abstract":"<p><strong>Introduction: </strong>Resveratrol (RES), a natural polyphenolic compound, has been linked to some beneficial effects against cardiovascular disease (CVD).</p><p><strong>Material and methods: </strong>We conducted a systematic search to conduct a meta-analysis on cardiometabolic risk factors modulated by RES targeting patients with metabolic syndrome (Met-S) and Obese/Healthy (O/H) subjects. The PICO (Patient, Intervention, Comparison, Outcome) research question was: Does RES among patients with Met-S and O/H subjects reduce the cardiometabolic risk? The first group was affected with MetS, which is defined as a clustering of abdominal obesity, dyslipidaemia, hyperglycaemia, and hypertension in a single individual. The second group was composed of 'obese/healthy' individuals, i.e. healthy subjects with or without obesity. We performed a literature search of MEDLINE/ PubMed, Scopus, and Google Scholar for randomised, controlled trials (RCT) that estimated the effects of RES on cardiometabolic risk factors.</p><p><strong>Results: </strong>We found 780 articles, of which 63 original articles and reviews were identified. Data from 17 well-conducted RCT studies, comprising 651 subjects, were extracted for analysis. Overall, RES had a significant influence on Homeostatic Model Assessment-Insulin Resistance (HOMA-IR), resulting in a mean difference of -0.520665 (95% CI: -1.12791; -0.01439; <i>p</i> = 0.00113). In Met-S, RES significantly reduced glucose, low-density lipoprotein-cholesterol (LDL-C), and total cholesterol (T-Chol) as detected by the mean difference of -1.069 (95% CI: -2.107, -0.032; <i>p</i> = 0.043), -0.924 (95% CI: -1.804, -0.043; <i>p</i> = 0.040), and -1.246 (95% CI: -2.314, -0.178; <i>p</i> = 0.022), respectively.</p><p><strong>Conclusions: </strong>Despite some heterogeneity in the populations, RES supplementation seems to improve cardiometabolic health, decreasing some risk factors (HOMA-IR, LDL-C, and T-Chol) associated with CVD.</p>","PeriodicalId":8317,"journal":{"name":"Archives of Medical Sciences. Atherosclerotic Diseases","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-05-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/29/c0/AMS-AD-5-40815.PMC7277462.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38036029","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}